Sequencing Reagents Market Size, Share & Trends Analysis Report By Technology, By Type, By Application (Oncology, Consumer Genomics), By End-use (Academic Research, Clinical Research), By Region, And Segment Forecasts, 2024

Description

Sequencing Reagents Market Growth & Trends:

The global sequencing reagents market size is expected to reach USD 23.33 billion by 2030, registering a CAGR of 17.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. Emergence of advanced and rapid high-throughput technologies, such as next-generation sequencing (NGS) and third-generation sequencing (TGS), for use in clinical applications provides lucrative growth avenues.

Moreover, a confluence of factors such as advent of targeted therapies in oncology and other clinical fields, development of companion diagnostics and precision medicine, and a significant reduction in the cost of genetic sequencing has increased the installation of NGS platforms throughout the globe. This, in turn, positively influences revenue generation for the market.

A substantial number of companies are using high-throughput technologies for drug discovery, which demands the use of genetic sequencing technologies. In addition, the application of NGS to accelerate early identification of autoimmune disorders is expected to drive the market. Moreover, parallel innovations in biomedical sciences have contributed to the growth of the NGS market.

Players in the industry are focused on in-depth research and development of new and effective reagents to stay ahead in the market. For instance, in October 2018, F. Hoffmann-La Roche AG introduced three NGS AVENIO Tumor Tissue Analysis Kits for detection of mutation in tumors. Similarly, in October 2019, QIAGEN launched an RNA-seq library preparation kit called QIAseq FastSelect RNA Removal Kit, designed for NGS. Companies are also expanding their businesses and setting up new facilities across the globe to gain a stronger foothold. For instance, in January 2019, BGI's subsidiary, MGI, installed 1,000 sequencers in 16 countries and opened an early access program for MGISEQ-T7 sequencer.

Sequencing Reagents Market Report Highlights:

Next-Generation sequencing dominated the market and accounted for a share of 89.9% in 2023. Next-generation sequencing (NGS) is extensively utilized in molecular diagnostics, pathology, and clinical research due to its cost efficiency and high throughput.
Sequencing kits segment dominated the market and accounted for a share of 35.9% in 2023 owing to the availability of major high-throughput platforms such as Illumina's MiniSeq, MiSeq, iSeq, NextSeq, HiSeq X, and NovaSeq series; Thermo Fisher Scientific's PGM, IonS5, and Ion Proton system; and Oxford Nanopore Technologies plc's MinION, GridION X5, and PromethION.
The oncology segment dominated the market and accounted for a share of 26.1% in 2023 due to high usage of sequencing reagents for clinical research and the advancement of cancer diagnostics and therapeutics.
Academic research segment dominated the market and accounted for a share of 51.7% in 2023 owing to the large number of universities and research centers offering molecular biology courses that extensively utilize next-generation sequencing (NGS) techniques.
North American sequencing reagents market dominated the market with revenue share of 49.73% in 2023 due to the high demand for sequencing reagents in the region.
Asia Pacific sequencing reagents market is anticipated to witness the fastest growth of 19.2% over the forecast period. This growth owes to the significantly increasing investments in genomics-focused biomedical research across the region.

Product Code: GVR-3-68038-683-7

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Sequencing Reagents Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Sequencing Reagents Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Sequencing Reagents Market: Technology Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Sequencing Reagents Market: Technology Movement Analysis, USD Million, 2023 & 2030
4.3. Sanger Sequencing
- 4.3.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Next-Generation Sequencing
- 4.4.1. Next-Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Third Generation Sequencing
- 4.5.1. Third Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Sequencing Reagents Market: Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Sequencing Reagents Market: Type Movement Analysis, USD Million, 2023 & 2030
5.3. Library Kits
- 5.3.1. Library Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Template Kits
- 5.4.1. Template Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Control Kits
- 5.5.1. Control Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Sequencing Kits
- 5.6.1. Sequencing Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Sequencing Reagents Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Sequencing Reagents Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Oncology
- 6.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Reproductive Health
- 6.4.1. Reproductive Health Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Clinical Investigation
- 6.5.1. Clinical Investigation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Agrigenomics and forensics
- 6.6.1. Agrigenomics and Forensics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Consumer Genomics
- 6.7.1. Consumer Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Others
- 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Sequencing Reagents Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Sequencing Reagents Market: End Use Movement Analysis, USD Million, 2023 & 2030
7.3. Academic Research
- 7.3.1. Academic Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Clinical Research
- 7.4.1. Clinical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Hospital and Clinics
- 7.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Pharmaceutical & biotechnology Companies
- 7.6.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others
- 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Sequencing Reagents Market: Regional Estimates & Trend Analysis

8.1. Sequencing Reagents Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
- 8.2.1. North America Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. U.S. Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Canada Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. Mexico
  - 8.2.4.1. Mexico Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
- 8.3.1. Europe Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. UK
  - 8.3.2.1. UK Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Germany
  - 8.3.3.1. Germany Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. France
  - 8.3.4.1. France Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Italy Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Spain Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Denmark Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Sweden Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Norway Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Japan Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. China
  - 8.4.3.1. China Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
  - 8.4.4.1. India Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Australia
- 8.4.6. South Korea
  - 8.4.6.1. South Korea Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
  - 8.4.7.1. Thailand Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
- 8.5.1. Latin America Sequencing Reagent Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Brazil Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Argentina
  - 8.5.3.1. Argentina Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. South Africa Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. Saudi Arabia Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. UAE
  - 8.6.4.1. UAE Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
  - 8.6.5.1. Kuwait Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific Inc.
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Illumina, Inc.
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. QIAGEN
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. BGI
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. PacBio
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. F. Hoffmann-La Roche Ltd
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Oxford Nanopore Technologies plc.
  - 9.4.7.1. Participant's Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. Agilent Technologies, Inc.
  - 9.4.8.1. Participant's Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. Standard BioTools (Fluidigm Corporation)
  - 9.4.9.1. Participant's Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. Integrated DNA Technologies, Inc. (ArcherDX, Inc.)
  - 9.4.10.1. Participant's Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Recent Developments/ Strategic Initiatives
- 9.4.11. Takara Bio Inc.
  - 9.4.11.1. Participant's Overview
  - 9.4.11.2. Financial Performance
  - 9.4.11.3. Product Benchmarking
  - 9.4.11.4. Recent Developments/ Strategic Initiatives
- 9.4.12. Meridian (Bioline)
  - 9.4.12.1. Participant's Overview
  - 9.4.12.2. Financial Performance
  - 9.4.12.3. Product Benchmarking
  - 9.4.12.4. Recent Developments/ Strategic Initiatives

Sequencing Reagents Market Size, Share & Trends Analysis Report By Technology, By Type, By Application (Oncology, Consumer Genomics), By End-use (Academic Research, Clinical Research), By Region, And Segment Forecasts, 2024 - 2030